日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Enterobacter agglomerans Mercuric reductase (merA), partial CSB-YP309059EKP
CSB-EP309059EKP
CSB-BP309059EKP
CSB-MP309059EKP
CSB-EP309059EKP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aggregatibacter actinomycetemcomitans 50S ribosomal protein L3 (rplC) CSB-YP309060AYK
CSB-EP309060AYK
CSB-BP309060AYK
CSB-MP309060AYK
CSB-EP309060AYK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aminopeptidase G (pepG) CSB-YP309061LAS
CSB-EP309061LAS
CSB-BP309061LAS
CSB-MP309061LAS
CSB-EP309061LAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanopyrus kandleri Uncharacterized protein MK0008 (MK0008) CSB-YP309062MSI
CSB-EP309062MSI
CSB-BP309062MSI
CSB-MP309062MSI
CSB-EP309062MSI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus sp. Biotin synthase (bioB) CSB-YP309063MFI
CSB-EP309063MFI
CSB-BP309063MFI
CSB-MP309063MFI
CSB-EP309063MFI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lysylphosphatidylglycerol biosynthesis bifunctional protein LysX (lysX), partial CSB-YP309064MVZ
CSB-EP309064MVZ
CSB-BP309064MVZ
CSB-MP309064MVZ
CSB-EP309064MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium tuberculosis Putative lipoprotein lppB (lppB) CSB-YP309065MVZ
CSB-EP309065MVZ
CSB-BP309065MVZ
CSB-MP309065MVZ
CSB-EP309065MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative S-adenosyl-L-methionine-dependent methyltransferase Rv0726c/MT0751 (Rv0726c, MT0751) CSB-YP309066MVZ
CSB-EP309066MVZ
CSB-BP309066MVZ
CSB-MP309066MVZ
CSB-EP309066MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable 8-oxo-dGTP diphosphatase 1 (mutT1) CSB-YP309067MVZ
CSB-EP309067MVZ
CSB-BP309067MVZ
CSB-MP309067MVZ
CSB-EP309067MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized oxidoreductase Rv2971/MT3049 (Rv2971, MT3049) CSB-YP309068MVZ
CSB-EP309068MVZ
CSB-BP309068MVZ
CSB-MP309068MVZ
CSB-EP309068MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Universal stress protein Rv3134c/MT3220 (Rv3134c, MT3220) CSB-YP309069MVZ
CSB-EP309069MVZ
CSB-BP309069MVZ
CSB-MP309069MVZ
CSB-EP309069MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Long-chain-fatty-acid--AMP ligase FadD30 (fadD30), partial CSB-YP309070MVZ
CSB-EP309070MVZ
CSB-BP309070MVZ
CSB-MP309070MVZ
CSB-EP309070MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable ribonuclease VapC14 (vapC14) CSB-YP309071MVZ
CSB-EP309071MVZ
CSB-BP309071MVZ
CSB-MP309071MVZ
CSB-EP309071MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanothermobacter marburgensis Nitrogenase molybdenum-iron protein beta chain (nifK) CSB-YP309072MSQ
CSB-EP309072MSQ
CSB-BP309072MSQ
CSB-MP309072MSQ
CSB-EP309072MSQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Myxococcus xanthus Protein grpE (grpE) CSB-YP309073MXB
CSB-EP309073MXB
CSB-BP309073MXB
CSB-MP309073MXB
CSB-EP309073MXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cell division protein FtsX homolog (ftsX), partial CSB-YP309074NFZ1
CSB-EP309074NFZ1
CSB-BP309074NFZ1
CSB-MP309074NFZ1
CSB-EP309074NFZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup B Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (lpxA) CSB-YP309075NGG
CSB-EP309075NGG
CSB-BP309075NGG
CSB-MP309075NGG
CSB-EP309075NGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Reverse gyrase (rgy), partial CSB-YP309076FHW
CSB-EP309076FHW
CSB-BP309076FHW
CSB-MP309076FHW
CSB-EP309076FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella haemolytica Der GTPase-activating protein YihI (yihI) CSB-YP309077ESE
CSB-EP309077ESE
CSB-BP309077ESE
CSB-MP309077ESE
CSB-EP309077ESE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Apocytochrome f (petA), partial CSB-YP309078PIB1
CSB-EP309078PIB1
CSB-BP309078PIB1
CSB-MP309078PIB1
CSB-EP309078PIB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×